Yüklüyor......
Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway
Atrial fibrillation along with accessory pathway–induced ventricular pre-excitation may be life-threatening due to the high risk of developing severe hypotension, ventricular fibrillation, and sudden death. We demonstrate nifekalant as an effective agent in the pharmacological cardioversion of atria...
Kaydedildi:
| Yayımlandı: | JACC Case Rep |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8298543/ https://ncbi.nlm.nih.gov/pubmed/34317211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2019.10.042 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|